Cookie Consent by
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
Latest News:

Genekam developed PCR kits for Candida auris.

Latest News:

Genekam registered with EUDAMED - A step towards meeting the latest IVDR requirements!

  • ++BREAKING NEWS (26.05.2020)++

    Plasma therapy accelerator (SARS-Hunter): a new solution for better antibody therapy for all coronavirus patients.

  • MEDICA 2023

    Visit us on Medica, Duesseldorf. 13.-16. November 2023

T-cell immunotherapy solution - car T-cell therapy

There are many laboratories developing CAR T-cell therapies. Genekam has a number of kits to develop CAR T-Cell therapy e.g. isolate large number of T cells (CD4 / CD8) from blood or other source. This isolation kit will generate larger number of needed T cells against number of cells generated through density gradient methods (also called Ficolle), Magnetic beads based Kits are for separation of wanted T cells from other unwanted cells. After that they can be stimulated or undergo the cloning with specific vectors carrying specific sequences. Genekam has developed a kit, which can remove the unwanted erythrocytes, which may be disturbing factors during the development. This can accelerate the development of CAR T-cells therapies against any possible target in field oncology, virology or transplantation medicine. These kits help to make therapies economically.